| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |